InvivoGen was founded in 1997 by scientists with technical expertise and creative excellence stemming from a longstanding history in microbiology. InvivoGen's unparalleled skill in microbial fermentation enables us to provide a wide range of biological molecules, including ultra-pure antibiotics, novel mycoplasma treatments and the largest collection of pattern recognition receptor agonists derived from a wide range of micro-organisms.
In addition we boast strong chemistry and molecular biology teams for the synthesis of molecules and plasmids for research use and studies focused on gene therapy and vaccination. Moreover, our specialized study of the innate immune receptor signaling pathways has resulted in the collection of reporter cell lines, which are routinely used for in-house quality control and research and development.
Our mission is to advance scientific understanding and medicine by providing solutions for cell and gene therapy and biomedical research. We believe in biomedical science as the strongest driver to change the way we treat cancer, autoimmune diseases, and neurodegenerative disorders. The design of therapeutics is evolving away from chemistry-based science towards individual treatments that focus on cell-based approaches and more targeted drugs. We are driving the revolution that is reinventing medicine and advancing it to a level that will make cancer and other serious diseases history.
The CIRI (Centre International de Recherche en Infectiologie) brings together the scientific and medical research communities in infectious diseases and immunity in the Lyon-St Etienne area, with the University of Lyon 1, Inserm, CNRS and ENS de Lyon as main managing bodies, and Hospices Civils de Lyon and Université Jean Monnet as secondary managing bodies, and important partnerships with VetAgroSup and Institut Pasteur. More than 400 researchers with complementary disciplinary backgrounds are grouped into 3 main departments: immunologists, bacteriologists and virologists, some of them being as well as cancerologists and epidemiologists. They work together with the main objective of understanding the biology of microbes and the immune system, and the interactions between microbes and their hosts, in order to better combat infectious diseases and other illnesses involving the immune system.
Proteintech is an antibody manufacturer selling directly to scientists and only selling its own products to maintain the highest level of quality control leading to superior reproducibility and lot consistency. With over 2/3 target coverage of proteins encoded by the human genome, Proteintech’s 12,000+ antibodies are used every day by scientists all over the world in a wide spectrum of research areas.
We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster.
With Tebubio, you can concentrate your efforts and accelerate what’s most important to you: Your Research.
Loading... 
